GemmaCert
Cannabis Quality Detection and Analysis
Company Overview
Snapshot
Founded in June 2015 by Guy Setton and Oded Shoseyov, GemmaCert operated with 11–50 employees. The company secured funding across 3 rounds from 7 investors, totaling $6.75 million. In April 2024, GemmaCert ceased operations.
Business overview
GemmaCert develops nondestructive and noninvasive analytical devices for precise verification of cannabis flower potency. The company's technology combines advanced optics and imaging analysis to provide real-time results without requiring sample preparation, making it suitable for growers, processors, distributors, and dispensaries. It operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Cannabis and Ag Tech, and serves markets including the United States, Europe, and Israel.
Strategic signal
GemmaCert ceased operations in April 2024. This indicates a significant downturn in the company's trajectory, signaling to investors and innovation teams that the business model or market conditions were unsustainable, leading to its closure.
Log in to access full profile ›Company Intelligence Q&A
- What is GemmaCert's primary focus?
- GemmaCert focuses on developing nondestructive and noninvasive analytical devices for the precise verification of cannabis flower potency, serving the medical cannabis and ag tech sectors.
- When was GemmaCert founded and by whom?
- GemmaCert was founded in June 2015 by Guy Setton and Oded Shoseyov.
- What was the total capital raised by GemmaCert?
- GemmaCert raised a total of $6.75 million across 3 funding rounds.
- What was a key development for GemmaCert in November 2018?
- In November 2018, GemmaCert announced new international distribution partnerships, expanding its market reach for cannabis testing devices.
- What is the current operational status of GemmaCert?
- GemmaCert ceased to operate in April 2024, and is currently classified as Non Active.